Salguero-Aranda, C.; Martínez-Reguera, P.; Marcilla, D.; de Álava, E.; Díaz-Martín, J.
Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors. Cancers 2021, 13, 5237.
https://doi.org/10.3390/cancers13205237
AMA Style
Salguero-Aranda C, Martínez-Reguera P, Marcilla D, de Álava E, Díaz-Martín J.
Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors. Cancers. 2021; 13(20):5237.
https://doi.org/10.3390/cancers13205237
Chicago/Turabian Style
Salguero-Aranda, Carmen, Paula Martínez-Reguera, David Marcilla, Enrique de Álava, and Juan Díaz-Martín.
2021. "Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors" Cancers 13, no. 20: 5237.
https://doi.org/10.3390/cancers13205237
APA Style
Salguero-Aranda, C., Martínez-Reguera, P., Marcilla, D., de Álava, E., & Díaz-Martín, J.
(2021). Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors. Cancers, 13(20), 5237.
https://doi.org/10.3390/cancers13205237